Detrusitol 1 mg filmcoated tablets
- Name:
Detrusitol 1 mg filmcoated tablets
- Company:
Pfizer Healthcare Ireland
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may be renewed (B)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 23/10/18

Click on this link to Download PDF directly
Pfizer Healthcare Ireland

Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 23 October 2018 PIL
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - marketing authorisation number
- Change to section 6 - date of revision
Updated on 19 October 2018 SPC
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 30 July 2015 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 30 July 2015 SPC
Reasons for updating
- Change to Section 4.8 – Undesirable effects - how to report a side effect
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
The SPC has been updated as follows.
Section 4.8 Reporting of suspected adverse reactions – QRD text added.
Updated on 28 July 2015 PIL
Reasons for updating
- New PIL for new product
Updated on 28 July 2015 PIL
Reasons for updating
- Change to side-effects
Updated on 9 April 2013 SPC
Reasons for updating
- Change to section 6.5 - Nature and contents of container
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
or PP Child Resistant Squeeze and Turn closures.
Updated on 14 May 2012 SPC
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - MA number
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 9 May 2012 PIL
Reasons for updating
- Change of licence holder
- Change to date of revision
- Change in co-marketing arrangement
Updated on 20 February 2012 PIL
Reasons for updating
- PIL re-instated
Updated on 20 January 2012 PIL
Reasons for updating
- Change to date of revision
- Change to marketing authorisation holder
Updated on 29 July 2010 PIL
Reasons for updating
- Change of manufacturer
Updated on 10 December 2008 PIL
Reasons for updating
- Change to side-effects
Updated on 9 December 2008 SPC
Reasons for updating
- Change to section 4.8 - Undesirable effects
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Section 4.8 has been updated to include the most common side effects with the tabulated listing.
Updated on 15 July 2008 SPC
Reasons for updating
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.8 - Undesirable effects
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 15 July 2008 PIL
Reasons for updating
- Change to drug interactions
- Change to side-effects
Updated on 7 March 2008 SPC
Reasons for updating
- Correction of spelling/typing errors
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 6 December 2007 SPC
Reasons for updating
- Change to section 7 - Marketing authorisation holder
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
7.0 – Marketing Authorisation Holder (Address)
Updated on 6 December 2007 PIL
Reasons for updating
- Change to marketing authorisation holder address
Updated on 14 June 2007 PIL
Reasons for updating
- Change to side-effects
Updated on 18 May 2007 SPC
Reasons for updating
- Change to section 4.8 - Undesirable effects
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
4.8 – Revision of section to more closely align with the core data sheet
Updated on 20 April 2007 PIL
Reasons for updating
- Change due to harmonisation of patient information leaflet
Updated on 17 April 2007 SPC
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.2 - Posology and method of administration
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.8 - Undesirable effects
- Change to section 4.9 - Overdose
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 5.2 - Pharmacokinetic properties
- Change to section 6.6 - Special precautions for disposal and other handling
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Section 2 addition of wording to increase clarity
Section 4.2 amended wording regarding paediatric use
Section 4.5 minor grammatical change to text
Section 4.8 inclusion of text on experience with paediatric use
Section 4.9 minor grammatical change to text
Section 5.1 inclusion of text on experience with paediatric use
Section 5.2 inclusion of text on experience with paediatric use
Section 6.6 Update in line with current EU guidelines
Updated on 28 November 2005 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change to date of revision
Updated on 11 November 2005 SPC
Reasons for updating
- Change to section 4.1 - Therapeutic indications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 4.9 - Overdose
- Change to section 5.1 - Pharmacodynamic properties
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 16 November 2004 PIL
Reasons for updating
- New PIL for medicines.ie
Updated on 6 August 2004 SPC
Reasons for updating
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.6 - Pregnancy and lactation
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 5.2 - Pharmacokinetic properties
- Change to section 5.3 - Preclinical safety data
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 3 July 2003 SPC
Reasons for updating
- New SPC for medicines.ie
Legal category: Product subject to medical prescription which may be renewed (B)